Výsledky vyhledávání

Akademický článek

LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours.

Autor: Scarzello AJ; Cancer and Inflamation Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Jiang Q; Cancer and Inflamation Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Back T; Cancer and Inflamation Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Dang H; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Hodge D; Cancer and Inflamation Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Hanson C; Cancer and Inflamation Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Subleski J; Cancer and Inflamation Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Weiss JM; Cancer and Inflamation Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Stauffer JK; Cancer and Inflamation Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Chaisaingmongkol J; Chulabhorn Research Institute, Bangkok, Thailand., Rabibhadana S; Chulabhorn Research Institute, Bangkok, Thailand., Ruchirawat M; Chulabhorn Research Institute, Bangkok, Thailand., Ortaldo J; Cancer and Inflamation Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Wang XW; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Norris PS; Infectious and Inflammatory Diseases Research Center, Sanford Burnham Medical Research Institute, La Jolla, California, USA., Ware CF; Infectious and Inflammatory Diseases Research Center, Sanford Burnham Medical Research Institute, La Jolla, California, USA., Wiltrout RH; Cancer and Inflamation Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.

Publikováno v: Gut [Gut] 2016 Oct; Vol. 65 (10), pp. 1765-75. Date of Electronic Publication: 2015 Jul 23.

Zobrazit plný text záznamu

Akademický článek

Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype.

Autor: Matter MS; Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Institute of Pathology, University Hospital of Basel, Basel, Switzerland., Marquardt JU; Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Department of Medicine I, Johannes Gutenberg University, Mainz, Germany., Andersen JB; Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark., Quintavalle C; Institute of Pathology, University Hospital of Basel, Basel, Switzerland., Korokhov N; Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Stauffer JK; Cancer and Inflammation Program, National Cancer Institute-Frederick, Frederick, MD., Kaji K; Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Decaens T; Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Quagliata L; Institute of Pathology, University Hospital of Basel, Basel, Switzerland., Elloumi F; National Cancer Institute, CCR at Leidos Inc., National Institutes of Health, Bethesda, MD., Hoang T; Institute of Pathology, University Hospital of Basel, Basel, Switzerland., Molinolo A; Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD., Conner EA; Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Weber A; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland., Heikenwalder M; Institute of Virology, Technische Universität München/Helmholtz Zentrum München, Munich, Germany.; Division of Chronic Inflammation and Cancer, German Cancer Research Center, Heidelberg, Germany., Factor VM; Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Thorgeirsson SS; Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Publikováno v: Hepatology (Baltimore, Md.) [Hepatology] 2016 Jun; Vol. 63 (6), pp. 1888-99. Date of Electronic Publication: 2016 Mar 15.

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Serum-based tracking of de novo initiated liver cancer progression reveals early immunoregulation and response to therapy.

Autor: Subleski JJ; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, United States., Scarzello AJ; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, United States., Alvord WG; Statistical Consulting, Data Management Services, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, United States., Jiang Q; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, United States., Stauffer JK; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, United States., Kronfli A; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, United States., Saleh B; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, United States., Back T; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, United States., Weiss JM; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, United States., Wiltrout RH; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, United States. Electronic address: wiltrour@mail.nih.gov.

Publikováno v: Journal of hepatology [J Hepatol] 2015 Nov; Vol. 63 (5), pp. 1181-9. Date of Electronic Publication: 2015 Jul 02.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání